Fabrizio Villa's current address is Department of Experimental Oncology, European Institute of Oncology, Via Adamello 16, 20139 Milan, Italy
Structure of the OSR1 kinase, a hypertension drug target
Article first published online: 2 SEP 2008
Copyright © 2008 Wiley-Liss, Inc.
Proteins: Structure, Function, and Bioinformatics
Volume 73, Issue 4, pages 1082–1087, December 2008
How to Cite
Villa, F., Deak, M., Alessi, D. R. and van Aalten, D. M. F. (2008), Structure of the OSR1 kinase, a hypertension drug target. Proteins, 73: 1082–1087. doi: 10.1002/prot.22238
- Issue published online: 29 OCT 2008
- Article first published online: 2 SEP 2008
- Accepted manuscript online: 2 SEP 2008 12:00AM EST
- Manuscript Accepted: 14 JUL 2008
- Manuscript Revised: 1 JUL 2008
- Manuscript Received: 19 MAY 2008
- Wellcome Trust Senior Research Fellowship
- Lister Research Prize
- Association for International Cancer Research
- Diabetes UK
- The Medical Research Council
- The Moffat Charitable Trust
- Gordon's syndrome;
- protein kinase;
- protein structure
The oxidative stress-responsive kinase-1 (OSR1) and STE20/SPS1-related proline/alanine-rich kinase (SPAK) interact, phosphorylate, and stimulate the activity of the cation-chloride cotransporters (NKCC1, NKCC2, and the Na+:Cl− cotransporter (NCC)).1–4 These cotransporters play key roles in regulating salt intake and secretion from cells (reviewed in Refs. 5,6). Some of the most commonly prescribed blood pressure-lowering thiazide drugs exert their physiological effects by inhibiting NCC. The SPAK and OSR1 enzymes are phosphorylated and activated by the WNK1 and WNK4 protein kinases in response to hyperosmotic and hypotonic stress.7–9 This may increase blood pressure by stimulating phosphorylation and activation of NCC.3 Consistent with this, WNK1 and WNK4 genes are mutated in patients suffering from an inherited hypertension and hyperkalemia (elevated plasma K+) disorder, termed pseudohypoaldosteronism type II.10, 11
SPAK and OSR1 are 68% identical in sequence and possess a highly similar kinase catalytic domain as well as a conserved C-terminal (CCT) domain.4 The CCT domain operates as a docking site enabling OSR1 and SPAK to interact with RFXV (Arg-Phe-Xaa-Val) motifs found in both their upstream activators as well as their substrates.2, 12, 13 Structural analysis revealed that the CCT domain forms a novel protein fold.14 The WNK1 and WNK4 protein kinases phosphorylate OSR1 and SPAK at their T-loop residue within the kinase catalytic domain (Thr185 in OSR1, Thr233 in SPAK).9
It is possible that inhibition of the WNK/OSR1/NCC phosphorylation cascade with kinase inhibitors may provide an alternative chemotherapeutic approach to direct inhibition of NCC. As a first step towards this, we describe the first crystal structure of an OSR1 fragment encompassing the catalytic domain of the enzyme.
General methods and DNA constructs
Restriction enzyme digests, DNA ligations, and other recombinant DNA procedures were performed using standard protocols. The cloning of human OSR1 has been described previously.9
Cloning, Expression, and crystallization of the OSR1 kinase domain
A fragment corresponding to residues 1-303 of OSR1 (NCBI accession number O95747) was cloned into pGEX-6P-1 (GE Healthcare) as a Bamh1-Not1 insert. BL21 E. coli cells were transformed with the pGEX-OSR1(1-303) and were grown at 37°C until the OD600 reached 0.8. Subsequently, 0.15 mM IPTG was added, and the culture was grown at 26°C for 18 h. GST-OSR1 recombinant protein was affinity purified following standard protocol and the affinity tag removed through incubation with PreScission protease. OSR1 was then further purified on a Superdex 200 26/60 (GE Healthcare) equilibrated against 25 mM Tris/HCl pH 7.5, 150 mM NaCl and 1 mM DTT. Pure OSR1(1-303) protein was concentrated to 17 mg/ml and five-fold molar excess of a nonhydrolazable ATP analogue (AMP-PNP) was added. Vapor diffusion crystallization experiments were set up by mixing 0.75 μL of protein, 0.75 μL of mother liquor (0.15M magnesium chloride, 0.1M Tris pH 8, and 20% PEG3350).
X-ray data collection, structure solution and refinement
The crystals were cryoprotected in a solution containing mother liquor and 15% v/v PEG400, and then frozen in a nitrogen cryostream. Crystals used for phasing were soaked in mother liquor containing 10mM AuCN for ∼18 h and cryoprotected as earlier. A two-wavelength MAD data set was collected from the AuCN-soaked crystals (Table I). Phases were calculated with SOLVE,15 finding 11 Au sites with a figure of merit of 0.44. With the help of FFFear16 and MOLREP,17 four OSR1 molcules were located and the noncrystallographic symmetry operators found. Solvent flattening and four-fold averaging were then performed with DM18 and the resulting map was used as input for warpNtrace.19 Iterative model building with COOT20 and refinement with REFMAC21 in which the four molecules in the asymmetric unit were refined initially with strict NCS, but in the final stages independently, yielding the final model with statistics shown in Table I. Atomic coordinates and structure factors have been deposited in the Protein Data Bank under the PDB code 2vwi.
|Unit Cell (Å)||a = 74.13||a = 74.20|
|b = 99.90||b = 100.11|
|c = 158.52||c = 158.78|
|Resolution (Å)||20.0–2.15 (2.23–2.15)||20.0–2.40 (2.49–2.40)|
|Redundancy||13.6 (3.9)||9.2 (4.9)|
|Completeness (%)||98.7 (88.2)||99.8 (98.1)|
|Rmergea||0.065 (0.3)||0.055 (0.242)|
|I / σI||48.6 (2.8)||43.9 (5.1)|
|Number of groups|
|RMSD from ideal geometry|
|Bond length (Å)||0.006|
|Bond angles (°)||0.964|
|Ramachandran plot (%)|
|Most favoured region||90.7|
SAXS sample preparation, data collection and analysis
Full length OSR1(1-527) was expressed and purified as described earlier, concentrated to 8.6 mg/mL and 10mM DTT was added immediately prior to synchrotron measurements. Scattering data were collected at the beamline 2.1, Daresbury (UK). Data were corrected for buffer scattering and checked for radiation damage using the XOTOKO22 software. The scattering intensities curves were then analyzed with GNOM23 and the Dmax and radius of gyration (Rg) were calculated.
Homology modeling for OSR1 kinase active conformation was performed using the MODELLER software.24 All figures were made with PyMOL.
RESULTS AND DISCUSSION
Structure of the OSR1 kinase domain
Limited trypsin proteolysis of full-length protein led to the identification of a stable proteolytic fragment encompassing the catalytic domain [Fig. 1(A)]. OSR1(1-303) was cloned, expressed in E. coli and the protein crystallized from PEG solutions in presence of an excess of AMP-PNP. The OSR1 kinase domain assumes the classical bilobal kinase fold [Fig. 1(B)], which is similar to the canonical kinase structure of cyclic AMP-dependent protein kinase (PKA).25 The structure consists of a 5-stranded anti-parallel β-sheet with an α-helix (αC) connecting strands β3-β4 whilst the C-terminal lobe is mainly α-helical [Fig. 1(B)]. The overall structure of the OSR1 kinase domain is similar to the recently determined structures of some STE kinase group members (rms deviations for all Cα atoms in the TAO2,26 PAK1,27 PAK4,28 and MEK129 kinase domains are 1.3, 1.5, 1.2, and 1.5 Å, respectively).
The OSR1 kinase domain in the crystal adopts an inactive conformation, as evidenced by the absence of electron density for the activation segment (residues 175 to 189) including Thr185, the target of phosphorylation by WNK isoforms.7–9 Interestingly, the active site of the kinase is partially occupied by the N-terminus of the activation segment assuming an unusual two-turn helix, topologically resembling helix αL12 of CDK230 [Figs. 1(A) and 2(A–B)]. The conserved catalytic ion pair between Lys46 from β-strand 2 and Glu63 from α-helix C is also disrupted by steric hindrance of αL12 (positioning Lys46 and Glu63 12.5 Å apart) [Fig. 2(A)].
Activation segment dimerization
The most striking feature of the OSR1 structure is an exchange of activation segments between symmetry-related molecules. The four independent OSR1 molcules are arranged as pairs of dimers [Fig. 1(C)] and superposition of the α-carbon traces of the four molecules reveals a high degree of similarity with an average rmsd of 0.65 Å. This contact mainly involves hydrophobic interactions between the two molecules. Several residues, such as Trp192, Met193, Leu197, and Met198 from helix αEF are occupying a hydrophobic pocket made up from residues Met233, Val235, Leu236, and Leu240 (helix αG), residues Trp211 and Ile215 (helix αF) of the neighboring molecule [Fig. 1(C)].
Activation segment exchange between kinases has recently been highlighted as a mechanism of trans-autophosphorylation in kinases such as CHK2,31 SLK, LOK, and DAPK3.32 Although OSR1 is phosphorylated at its activation segment in vivo by the WNK enzymes,7–9 it is not clear whether the (homo)-dimerization seen in the crystal structure is structurally reminiscent of the trans-phosphorylation event or simply a crystallographic artefact. A recent study has shown that a fragment encompassing the catalytic kinase domain of OSR1(1-344) oligomerises in vivo in a similar manner as other STE group members.7 However, the OSR1(1-303) kinase domain is monomeric in solution as judged by size exclusion chromatography (data not shown) and from the X-ray solution scattering calculated parameters [Fig. 2(D)].
OSR1/SPAK active conformation
In an attempt to understand the molecular mechanism by which OSR1 is activated by WNK isoforms, we crystallized the Thr185Glu mutant, in order to mimic a form of OSR1 that was phosphorylated. However inspection of the electron density revealed that the OSR1[T185E] mutant was not in an active conformation, and we therefore decided to generate a homology-based structural model of OSR1 active conformation based on a multiple sequence alignment and the known structures of the STE20 related kinases [Fig. 1(A)]. The homology model of the OSR1 active conformation suggests that mainly Arg183, and Arg145 (RD motif) would be candidates for stabilizing the phospho-Thr185 [Figs. 1(A) and 2(C)], resembling the activation mechanism observed in the PAK subfamily members.27, 28 A multiple sequence alignment of OSR1, the closely related SPAK and other STE group members already crystallized (TAO2, PAK1, and PAK4), reveals that these residues are conserved in OSR1/SPAK [Fig. 1(A)]. Thus, this suggests that the active conformation of OSR1 and SPAK may be achieved through a similar mechanism previously observed for the PAK subfamily members PAK1,27 PAK428 [Figs. 1(A) and 2(C)] and reminiscent of PhK.33
Binding of OSR1 to the RFXV motif induces a large conformational change
Full length OSR1 in presence or absence of RFXV motif-containing peptides has so far resisted crystallization. We therefore attempted to study the solution conformation of full length OSR1 by small angle X-ray scattering (SAXS). For these studies, full-length OSR1(1-527) over-expressed and purified from E. coli was subjected to SAXS measurements in absence and in presence of a peptide derived from human WNK4, encompassing the RFXV motif necessary for binding to the OSR1 CCT domain.14, 34 From the resulting scattering curves, the radii of gyration (Rg) and maximum diameters (Dmax) were calculated [Fig. 2(D)]. OSR1 in the absence of the RFXV peptide assumed an elongated shape with a radius of gyration of 30.5 ± 0.1 Å and a Dmax of 92 ± 3 Å [Fig. 2(D)]. Addition of the WNK4 peptide to the OSR1 solution resulted in a markedly more compact molecule with a radius of gyration of 25.8 ± 0.1 Å and a Dmax of 78 ± 2 Å, suggesting that peptide binding induces a significant conformational change [Fig. 2(D)]. The reduction of Dmax and Rg of the OSR1-RFXV peptide complex in solution might suggest a large movement of the conserved C-terminal (CCT) domain towards the catalytic domain of the protein [Fig. 2(D)]. It is therefore possible that the binding of the conserved C-terminal (CCT) to the RFXV peptide induces a conformational change required for OSR1 to be efficiently phosphorylated by WNKs and to efficiently phosphorylate the substrates without affecting the catalytic efficiency of the enzyme.
The authors thank the European Synchroton Radiation Facility (Grenoble, France) for beam time at BM14 and the Synchroton Radiation Source (Daresbury, UK) for beam time at the 2.1 station.
- 6Role of WNK kinases in regulating tubular salt and potassium transport and in the development of hypertension Am J Physiol Renal Physiol 2005; 28: 245–252..